January 30, 2025 | Client News, NASDAQ: AMST
Customer Wins in $130B Market Highlighted DETROIT, Jan. 30, 2025 (GLOBE NEWSWIRE) — Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, will be at NASDAQ tomorrow with CEO Dr. Ann Marie Sastry for a media event to include appearing on the NASDAQ Tower in Times Square. […]
January 30, 2025 | Client News, NASDAQ: AMST
CEO to Provide Update on Company’s NurseMagic™ App DETROIT, Jan. 29, 2025 (GLOBE NEWSWIRE) — Amesite, Inc. (Nasdaq:AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference is taking place […]
January 29, 2025 | Client News
Ciulla has over a decade of leadership experience in operations, acquisition integration and business development within the veterinary sector VIRGINIA BEACH, VA / ACCESS Newswire / January 29, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S., today announced the appointment of Samatha A. […]
January 29, 2025 | Client News
Non-dilutive financing preserves shareholder value as the Board anticipates a re-rating of the stock later this year amidst surging business momentum NEW YORK, Jan. 29, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven retail and eCommerce solutions, announces the successful arrangement of a $30 million unsecured loan facility with Joh. […]
January 29, 2025 | Client News
MIAMI, FLORIDA / ACCESS Newswire / January 29, 2025 / Cyberattacks are one of the most pressing threats to global stability, disrupting not just industries but entire economies. From the Stuxnet malware to the infamous Colonial Pipeline attack, cyber incidents have targeted critical infrastructure and operational technologies (OT), showcasing their devastating physical and financial consequences. These breaches highlight […]
January 29, 2025 | Client News
SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ. Event Information: Event NanoViricides Presentation at the MicroCap Conference, […]
January 28, 2025 | Client News
MIAMI, FL / ACCESS Newswire / January 28, 2025 / SMX (Security Matters) Ltd. (NASDAQ:SMX) and Ybyrá Capital S.A. are on the brink of a transformative partnership poised to redefine Brazil’s role in global trade. Announced in December 2024 and updated in a recent 6-K filing, the referenced Heads of Agreement reflect a shared vision to revolutionize supply […]
January 28, 2025 | Client News
Delivering high-performance AI without the ‘black hole of capital’ required by traditional LLMs, showing that smarter, leaner models can drive better Ai outcomes NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a leader in AI-driven retail innovation, proudly announces that its groundbreaking large language model, brainpowa, has been engineered from the very […]
January 27, 2025 | Client News
SHELTON, CT / ACCESS Newswire / January 27, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum antiviral drug NV-387 further into the regulatory pipeline. “NV-387, our broad-spectrum antiviral drug is poised to cause a revolution in treatment […]